Search details
1.
Glycan Structures in Osteosarcoma as Targets for Lectin-Based Chimeric Antigen Receptor Immunotherapy.
Int J Mol Sci
; 25(10)2024 May 14.
Article
in English
| MEDLINE | ID: mdl-38791381
2.
Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy.
Gene Ther
; 30(7-8): 603-611, 2023 08.
Article
in English
| MEDLINE | ID: mdl-36529796
Results
1 -
2
de 2
1
Next >
>>